SCHEMBL4332922

SCHEMBL4332922

CCOC(C(N)=O)n1nc(-c2cc3ccccc3s2)c2c(OC)c(C(=O)O)ccc21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 1/20 0.39
JAK3 P52333 1/20 0.39
ACLY P53396 1/20 0.36
TNFRSF1A P19438 6/20 0.35
IKBKB O14920 1/20 0.35
PIK3CD O00329 1/20 0.35
PIK3CA P42336 1/20 0.35
PIK3CB P42338 1/20 0.35
PIK3CG P48736 1/20 0.35
PRKDC P78527 1/20 0.35
ALOX5 P09917 1/20 0.34
PTGS1 P23219 1/20 0.34
PTGS2 P35354 1/20 0.34
ERN1 O75460 1/20 0.33
PLAU P00749 1/20 0.33
KDM4C Q9H3R0 1/20 0.33
PGK1 P00558 1/20 0.32
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4334931 0.85 ACLY (0.37) JAK2JAK3ACLYTNFRSF1AIKBKB
SCHEMBL4331815 0.84 JAK2 (0.37) JAK2JAK3PIK3CDPIK3CAPIK3CB
SCHEMBL4339893 0.82 ACLY (0.35) JAK2JAK3ACLYTNFRSF1AIKBKB
SCHEMBL4335815 0.81 PIK3CD (0.35) JAK2JAK3ACLYTNFRSF1AIKBKB
SCHEMBL4332589 0.78 ACLY (0.33) JAK2JAK3ACLYTNFRSF1AIKBKB
SCHEMBL4332493 0.71 IKBKB (0.36) JAK2JAK3ACLYIKBKBPIK3CD
SCHEMBL2857820 0.70 ACLY (0.42) JAK2JAK3ACLYTNFRSF1AIKBKB
SCHEMBL2865454 0.69 JAK2 (0.41) JAK2JAK3TNFRSF1AIKBKBPIK3CD
SCHEMBL4335926 0.69 IKBKB (0.35) JAK2JAK3ACLYIKBKBPIK3CD
SCHEMBL4348179 0.68 SRC (0.37) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 JAK2 145/4885JAK3 776/4885ACLY 2587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.